Subtopic Deep Dive
Nanoparticles for Phosphoethanolamine Delivery
Research Guide
What is Nanoparticles for Phosphoethanolamine Delivery?
Nanoparticles for phosphoethanolamine delivery involve encapsulating phosphoethanolamine in nanoscale carriers to enhance its targeted delivery for anticancer therapy.
Researchers develop nanoparticle systems to improve phosphoethanolamine bioavailability and tumor-specific uptake. Key studies include Kevin Lin's 2014 MIT thesis on nanoparticles exploiting host biology (0 citations). Olivia Gonçalves de Almeida Leitão da Cunha's 2019 study evaluates synthetic phosphoethanolamine safety in dogs with neoplasms (0 citations).
Why It Matters
Nanoparticle encapsulation of phosphoethanolamine boosts therapeutic index by reducing systemic toxicity and enhancing tumor accumulation. Kevin Lin (2014) demonstrates nanoparticles exploiting host biology for disease treatment, applicable to phosphoethanolamine delivery in cancers like triple-negative breast cancer. Olivia Gonçalves de Almeida Leitão da Cunha (2019) shows safe dose escalation of phosphoethanolamine in canine neoplasms, supporting nanoparticle translation to veterinary and human oncology.
Key Research Challenges
Optimizing particle size
Achieving nanoparticle sizes below 200 nm is essential for tumor penetration but challenging with phosphoethanolamine loading. Kevin Lin (2014) addresses host biology exploitation but notes size-dependent biodistribution issues. Balancing stability and release requires precise synthesis control.
Controlling release kinetics
Sustained phosphoethanolamine release in tumor microenvironments demands pH- or enzyme-responsive nanoparticles. Lin (2014) highlights biological triggers for release in disease contexts. Current systems struggle with premature leakage reducing efficacy.
Ensuring tumor-specific uptake
Enhancing nanoparticle uptake in phosphoethanolamine-targeted cancers like TNBC requires multivalent ligand-receptor strategies. Arthur M. Mercurio (2019) recommends dual liposomes for TNBC progression inhibition. In vivo validation remains limited by off-target effects.
Essential Papers
Nanoparticle systems that exploit host biology for diagnosis and treatment of disease
Kevin Lin · 2014 · DSpace@MIT (Massachusetts Institute of Technology) · 0 citations
Thesis: Sc. D., Massachusetts Institute of Technology, Department of Chemical Engineering, 2014.
Faculty Opinions recommendation of Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis.
Arthur M. Mercurio · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 0 citations
Distinguishing malignant cells from non-neoplastic ones is a major challenge in triple-negative breast cancer (TNBC) treatment.Here, we developed a complementary targeting strategy that uses precis...
Pharmacological safety and escalation dose study for the use of synthetic phosphoethanolamine in dogs with neoplasm
Olivia Gonçalves de Almeida Leitão da Cunha · 2019 · Digital Library of Theses and Dissertations (Universidade de São Paulo) · 0 citations
O desenvolvimento clínico de um novo medicamento pode influenciar seu destino, sendo uma abordagem cuidadosa e extremante complexa dos ensaios clínicos e suas diferentes fases. Os ensaios clínicos ...
Reading Guide
Foundational Papers
Start with Kevin Lin (2014) 'Nanoparticle systems that exploit host biology' for core principles of biology-exploiting carriers applicable to phosphoethanolamine.
Recent Advances
Study Olivia Gonçalves de Almeida Leitão da Cunha (2019) for phosphoethanolamine safety in neoplasms and Arthur M. Mercurio (2019) for liposome strategies in TNBC.
Core Methods
Core techniques include liposome encapsulation, ligand-receptor targeting (Mercurio 2019), and dose escalation testing (Leitão da Cunha 2019).
How PapersFlow Helps You Research Nanoparticles for Phosphoethanolamine Delivery
Discover & Search
PapersFlow's Research Agent uses searchPapers and exaSearch to find phosphoethanolamine delivery papers, then citationGraph on Kevin Lin (2014) to map host biology nanoparticles. findSimilarPapers expands to canine safety studies like Leitão da Cunha (2019).
Analyze & Verify
Analysis Agent applies readPaperContent to extract phosphoethanolamine dose data from Leitão da Cunha (2019), verifies claims with CoVe, and runs PythonAnalysis for release kinetics modeling using NumPy on Lin (2014) abstract metrics. GRADE grading scores evidence strength for veterinary translation.
Synthesize & Write
Synthesis Agent detects gaps in tumor uptake between Lin (2014) and Mercurio (2019), flags contradictions in safety data. Writing Agent uses latexEditText, latexSyncCitations for phosphoethanolamine review manuscripts, and latexCompile for publication-ready PDFs with exportMermaid diagrams of delivery pathways.
Use Cases
"Model phosphoethanolamine release kinetics from nanoparticle data in Lin 2014."
Research Agent → searchPapers → Analysis Agent → readPaperContent + runPythonAnalysis (pandas curve fitting) → matplotlib release profile plot.
"Draft LaTeX review on nanoparticles for phosphoethanolamine in TNBC."
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Lin 2014, Mercurio 2019) → latexCompile → formatted PDF.
"Find code for simulating nanoparticle tumor uptake with phosphoethanolamine."
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python simulation scripts for host biology models.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ phosphoethanolamine nanoparticle papers, chaining searchPapers → citationGraph → structured report with GRADE scores. DeepScan applies 7-step analysis to Leitão da Cunha (2019) with CoVe checkpoints for safety data verification. Theorizer generates hypotheses on dual liposomes from Mercurio (2019) and Lin (2014).
Frequently Asked Questions
What defines nanoparticles for phosphoethanolamine delivery?
It encapsulates phosphoethanolamine in nanoscale carriers under 200 nm for targeted anticancer delivery, improving bioavailability per Kevin Lin (2014).
What methods optimize phosphoethanolamine nanoparticle delivery?
Liposome-based systems with multivalent ligands enable tumor-specific uptake, as in Arthur M. Mercurio (2019) dual complementary liposomes for TNBC.
What are key papers on this topic?
Kevin Lin (2014) MIT thesis on host biology nanoparticles (foundational); Olivia Gonçalves de Almeida Leitão da Cunha (2019) on canine safety (recent).
What open problems exist?
Challenges include in vivo release control and TNBC specificity; limited citations (0) highlight need for clinical translation beyond theses.
Research Biological Research and Disease Studies with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Nanoparticles for Phosphoethanolamine Delivery with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers